Geron (NASDAQ: GERN) director awarded stock options for 220,000 shares at $1.26

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

GERON CORP director Elizabeth G. O'Farrell received a grant of stock options covering 220,000 shares of common stock. The options have an exercise price of $1.26 per share and expire on May 19, 2036. They vest 100% on the earlier of the next annual stockholder meeting or the first anniversary of the grant date, subject to her continuous service with the company. After this grant, she holds 220,000 options directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider O'Farrell Elizabeth G.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	220,000	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 220,000 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Option grant size: 220,000 options Exercise price: $1.26 per share Underlying shares: 220,000 shares +2 more

5 metrics

Option grant size 220,000 options Stock Option (right to buy) granted to director on May 20, 2026

Exercise price $1.26 per share Exercise price for 220,000 underlying Geron common shares

Underlying shares 220,000 shares Common stock underlying the stock option grant

Expiration date May 19, 2036 Option expiration for the reported stock option grant

Post-transaction options held 220,000 options Total derivative securities held directly after the transaction

Key Terms

Stock Option (right to buy), exercise price, expiration date, continuous service, +1 more

5 terms

Stock Option (right to buy) financial

"security_title: "Stock Option (right to buy)""

exercise price financial

"conversion_or_exercise_price: "1.2600" per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: "2036-05-19T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

continuous service financial

"subject to the Reporting Person's continuous service with the Issuer"

grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Form 4 Insider Transactions: What Each Field Means →

05/26/2026 - 07:45 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Farrell Elizabeth G.

(Last)

(First)

(Middle)

C/O GERON CORPORATION

919 EAST HILLSDALE BOULEVARD, SUITE 250

(Street)

FOSTER CITY

CALIFORNIA

94404

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GERON CORP [ GERN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$1.26	05/20/2026		A		220,000		⁽¹⁾	05/19/2036	Common Stock	220,000	$0	220,000	D

Explanation of Responses:

1. This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the Reporting Person's continuous service with the Issuer through such dates.

	/s/ Michelle Robertson, Attorney-in-Fact	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Geron (GERN) director Elizabeth O'Farrell report in this Form 4?

Elizabeth G. O'Farrell reported receiving a grant of stock options for 220,000 Geron common shares. These options are a compensation-related award, not an open-market share purchase or sale, and are held directly in her name following the transaction.

How many Geron (GERN) shares are covered by Elizabeth O'Farrell’s new stock options?

The new stock option grant covers 220,000 underlying shares of Geron common stock. This entire amount was acquired in a single derivative transaction classified as a grant or award, leaving her with 220,000 stock options following the reported transaction.

What is the exercise price of Elizabeth O'Farrell’s Geron (GERN) stock options?

The options have an exercise price of $1.26 per share for Geron common stock. This means she can purchase up to 220,000 shares at $1.26 each once the options vest and become exercisable under the terms of the grant.

When do Elizabeth O'Farrell’s Geron (GERN) stock options vest?

The options vest and become fully exercisable on the earlier of the next annual meeting of Geron stockholders or the first anniversary of the grant date. Vesting is conditioned on her continuous service with Geron through the applicable vesting date.

When do Elizabeth O'Farrell’s Geron (GERN) stock options expire?

The reported stock options expire on May 19, 2036, if not exercised earlier. After this expiration date, any unexercised portion of the 220,000-share option grant will no longer be exercisable under the terms disclosed in the Form 4.

Is Elizabeth O'Farrell’s Geron (GERN) Form 4 a buy or a sale of shares?

The Form 4 reflects an acquisition via grant of stock options, not a market buy or sale. The transaction is coded as a grant or award of derivative securities providing the right to buy Geron common stock at a fixed exercise price.